Sushil and Aware strike gold, Babita settles for silver

Beijing/Zurich, Mar 4: China has approved the use of Swiss drugmaker Roche's anti-inflammation drug Actemra for patients who develop severe complications from the coronavirus as it urgently hunts for new ways to combat the deadly infection that is spreading worldwide.

China is hoping that some older drugs could stop severe cytokine release syndrome (CRS), or cytokine storms, an overreaction of the immune system which is considered a major factor behind catastrophic organ failure and death in some coronavirus patients.

Actemra, a biologic drug approved in 2010 in the United States for rheumatoid arthritis (RA), inhibits high Interleukin 6 (IL-6) protein levels that drive some inflammatory diseases.

China's National Health Commission said in treatment guidelines published online on Wednesday that Actemra can now be used to treat coronavirus patients with serious lung damage and high IL-6 levels.

Separately, researchers in the country are testing Actemra, known generically as tocilizumab, in a clinical trial expected to include 188 coronavirus patients and running until May 10.

Roche, which donated 14 million yuan ($2.02 million) worth of Actemra during February, said the trial was initiated independently by a third party with the aim of exploring the efficacy and safety of the drug in coronavirus patients with CRS.

It added that there was currently no published clinical trial data on the drug's safety or efficacy against the virus.

More than 3,000 people have died and 93,000 have been infected by the novel coronavirus thought to have originated in Wuhan, China, before spreading to around 90 countries including the United States, Italy, Switzerland, France and Germany.

The Swiss company, for which China is its No. 2 market behind the United States, also makes diagnostic gear to detect the coronavirus.

Since Actemra's approval a decade ago, it has become a go-to drug against other inflammatory conditions, including cytokine storms in cancer patients receiving cell therapies from Novartis and Gilead Sciences.

In 2012 it helped save the life of a young U.S. girl, the first child to be treated for leukaemia with Novatis' Kymriah, from a post-treatment rush of IL-6.

Priced at between $20-30,000 annually for RA according to SSR Health, Roche's medicine is also used for rare juvenile arthritis and giant cell arteritis, or inflammation of the blood vessels.

New Delhi, Jun 22: Claiming to be saddled with faulty equipment from China, the Indian Weightlifting Federation (IWLF) on Monday called for a boycott of sports apparatus made in that country after the violent face-off in eastern Ladakh killed 20 Army personnel last week.

The IWLF ordered four weightlifting sets, comprising barbells and weight plates, from Chinese company 'ZKC' last year. The body said that the equipment turned out to be faulty and the weightlifters are no longer using them.

"We should boycott all Chinese equipment. The Indian Weightlifting Federation has taken the decision that it will not use any equipment made in China," IWLF secretary general Sahdev Yadav said.

The IWLF, in a letter, has informed the Sports Authority of India (SAI) about its decision to stop using any equipment made in China.

"In a letter to SAI we have written that IWLF won't be using the Chinese equipment," he said.

"In future also we will not use made in china sets. We will use sets made by Indian origin companies or any other company but not from China," Yadav added.

National coach Vijay Sharma revealed that the plates were found to be sub-standard when the lifters started training again earlier this month following the easing of the COVID-19 lockdown restrictions.

"The sets were spoilt. We can't use them now," Sharma said.

"All the weightlifters in the camp are against China. They have stopped using Chinese apps like Tik Tok. Even while ordering things online, they check where the product has been manufactured," he added.

Asked why the sets were even ordered, Sharma said they had no option as the equipment from China is to be used in the Tokyo Olympics and lifters needed to be familiar with it.

"We had ordered four sets from China for Olympic training a year ago. Now, since we have resumed training post the lockdown we haven't used them. All the lifters are against the use of Chinese equipment," he said.

He said equipment was ordered from China for the first time.

"We don't order equipment from China as the quality is very bad. This was the first time we got it."

The weightlifters are currently training with equipment made in Sweden.

"Post the lockdown we started training on sets from Swedish company 'ELICKO'. SAI has issued 10 sets for us. The main training takes place with those. Maximum international competitions have sets from ELICKO," Sharma said.

Yadav also said that there are ready alternatives to Chinese equipment.

"We have a lot of alternatives. We already have good Indian sets and we also have equipment from Sweden. We will use that, why should we use Chinese?" Yadav said.

Calls to boycott China-made goods erupted across India after the Galwan valley clash last Monday. It was the most violent face-off between the troops from the two countries in more than four decades.

The Indian Olympic Association (IOA) has said it is open to boycotting Chinese products in the wake of the incident.

The BCCI will also review IPL's sponsorship deals, including the title deal with Chinese mobile manufacturing company Vivo later this week.

Melbourne, Apr 14: As all sporting action across the world has come to a halt due to the coronavirus pandemic, Australian bowlers are pondering as to how Indian skipper Virat Kohli might play in front of no spectators.

India and Australia are scheduled to play a four-match Test series later this year, and it is being speculated that the series might end up taking place without any crowds due to the COVID-19 pandemic.

Australian spinner Nathan Lyon on Tuesday said that it would be interesting to see how Kohli goes about it if he does not get a chance to get the audience behind him.

"He is probably good enough to adapt to any scenario. But I was talking to Mitch Starc the other day and we actually said that if we are playing with no crowd, it'll be quite amazing to see Virat trying to rev up the empty seats," cricket.com.au quoted Lyon as saying.

"It is going to be a little bit different, but Virat is a superstar. He will be able to adapt to any climate that we are able to play in," he added.
During the 2018-19 series, India managed to defeat Australia in Australia for the first time in a Test series.

Australia, at that time were without the services of David Warner and Steve Smith. However, the series later this year promises to be a mouth-watering prospect.

"I am excited about the prospect of India coming out to Australia, it's up there with the biggest series alongside the Ashes. They are an absolute powerhouse of the cricket world, and to have those guys out here is going to be fantastic. Playing in front of crowds or no crowds is out of our control, we have got to follow the advice of all the amazing medical people around the world," Lyon said.

"I have not thought about no crowds or massive crowds, it is just about the opportunity of playing against India again. They had the wood over us last time they came over here but we are a much stronger Australian cricket side at the moment, and I am just unbelievably excited about playing them here at home," he added.

Lyon was slated to represent Hampshire in County Championship this year, however, his stint was called off last week due to COVID-19.
He is Australia's third-highest wicket-taker in the longest format of the game as he has total of 390 wickets in Test cricket.

Lyon was last seen in action in the Big Bash League for Sydney Sixers.